Propeller Health and Boehringer Ingelheim Collaborate on COPD, Asthma Tools for Better Health – COPD News Today


Drug Discovery & Development

Propeller Health and Boehringer Ingelheim Collaborate on COPD, Asthma Tools for Better Health
COPD News Today
Boehringer Ingelheim Pharmaceuticals and Propeller Health are partnering to use digital health tools and services to help patients with asthma and chronic obstructive pulmonary disease (COPD) to better cope with their condition. Under the terms of the …
FDA Approves Supplemental New Drug Application (sNDA) for Boehringer Ingelheim's STIOLTO RESPIMAT for COPD PR Newswire (press release)
Boehringer Ingelheim Enters Commercial Partnership with Propeller HealthPharmaceutical Technology Magazine (press release) (blog)

all 3 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.